These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3068493)

  • 21. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation by Phoneutria nigriventer (armed spider) venom of tissue kallikrein-kininogen-kinin system in rabbit skin in vivo.
    Marangoni RA; Antunes E; Brain SD; de Nucci G
    Br J Pharmacol; 1993 Jun; 109(2):539-43. PubMed ID: 8395291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of sodium deoxycholic acid-induced scratching behaviour by bradykinin B2 receptor antagonists.
    Hayashi I; Majima M
    Br J Pharmacol; 1999 Jan; 126(1):197-204. PubMed ID: 10051136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hageman factor dependent pathway in local vascular permeability enhancement.
    Yamamoto T; Kozono K; Tsuruta J; Cochrane CG; Kambara T
    Adv Exp Med Biol; 1986; 198 Pt B():45-52. PubMed ID: 3812107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutral proteases of human PMN leukocytes with kininogenase activity.
    Movat HZ; Habal FM; MacMorine DR
    Int Arch Allergy Appl Immunol; 1976; 50(3):257-81. PubMed ID: 55389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.
    Matsumoto K; Yamamoto T; Kamata R; Maeda H
    J Biochem; 1984 Sep; 96(3):739-49. PubMed ID: 6438075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bradykinin and nitric oxide in infectious disease and cancer.
    Maeda H; Akaike T; Wu J; Noguchi Y; Sakata Y
    Immunopharmacology; 1996 Jun; 33(1-3):222-30. PubMed ID: 8856154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma protease and kinin release with special reference to plasmin.
    Hamberg U
    Ann N Y Acad Sci; 1968 Jun; 146(2):517-26. PubMed ID: 4240400
    [No Abstract]   [Full Text] [Related]  

  • 29. The Hageman factor-dependent system in the vascular permeability reaction.
    Yamamoto T; Kozono K; Kambara T; Cochrane CG
    Biochim Biophys Acta; 1988 Aug; 966(2):196-206. PubMed ID: 3401504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of [ethyl p-(6-guanidinohexanoyloxy)benzoate] methanesulfonate (FOY) on kinin formation and fibrinolysis activity].
    Aishita H; Okegawa T; Akimoto A; Makita T; Shimizu H
    Nihon Yakurigaku Zasshi; 1975 Jan; 71(1):89-99. PubMed ID: 169189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.
    He S; Walls AF
    Eur J Pharmacol; 1997 Jun; 328(1):89-97. PubMed ID: 9203574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local kallikrein and trypsin responses in the rat.
    Bennett AJ; West GB
    Br J Pharmacol; 1980 Aug; 69(4):625-9. PubMed ID: 6159938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased vascular permeability produced by human platelet granule cationic extract.
    Nachman RL; Weksler B; Ferris B
    J Clin Invest; 1970 Feb; 49(2):274-81. PubMed ID: 4391559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo.
    Oschatz C; Maas C; Lecher B; Jansen T; Björkqvist J; Tradler T; Sedlmeier R; Burfeind P; Cichon S; Hammerschmidt S; Müller-Esterl W; Wuillemin WA; Nilsson G; Renné T
    Immunity; 2011 Feb; 34(2):258-68. PubMed ID: 21349432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema.
    Teufel DP; Bennett G; Harrison H; van Rietschoten K; Pavan S; Stace C; Le Floch F; Van Bergen T; Vermassen E; Barbeaux P; Hu TT; Feyen JHM; Vanhove M
    J Med Chem; 2018 Apr; 61(7):2823-2836. PubMed ID: 29517911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of bradykinin generating and degrading systems in the vascular permeability response induced with kaolin in rats.
    Kumakura S; Tsurufuji S; Kurooka S; Sunahara N
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1067-73. PubMed ID: 3320343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of extracellular toxin(s) produced by Vibrio vulnificus.
    Kreger A; Lockwood D
    Infect Immun; 1981 Aug; 33(2):583-90. PubMed ID: 7024134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of exogenous histamine on the proteolytic activity, level of proteolysis inhibitors and on the state of the kallikrein-kinin system of the blood].
    Bogadel'nikov IV; Protsenko VZ; Spitsyn IF; Kharchenko VZ; Shaevskiĭ DV
    Patol Fiziol Eksp Ter; 1979; (1):51-4. PubMed ID: 311464
    [No Abstract]   [Full Text] [Related]  

  • 39. Vibrio vulnificus infection and metalloprotease.
    Miyoshi S
    J Dermatol; 2006 Sep; 33(9):589-95. PubMed ID: 16958802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse skin damage caused by cytolysin from Vibrio vulnificus and by V. vulnificus infection.
    Gray LD; Kreger AS
    J Infect Dis; 1987 Feb; 155(2):236-41. PubMed ID: 3805762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.